High-Risk Pedigree Study Identifies LRBA (rs62346982) as a Likely Predisposition Variant for Prostate Cancer.

Area of Science:

• Genetics
• Oncology
• Bioinformatics

Background:

• Inherited factors contribute to prostate cancer, particularly lethal forms, but causative genes remain largely unknown.
• Identifying these genetic variants is crucial for understanding disease mechanisms and developing targeted therapies.

Purpose of the Study:

• To identify rare genetic variants shared among affected cousins in high-risk prostate cancer pedigrees.
• To validate candidate variants for association with prostate cancer risk in larger cohorts and investigate their functional impact.

Main Methods:

• Whole-exome sequencing of 51 affected cousin pairs from high-risk prostate cancer pedigrees.
• Association testing of shared rare variants in UK Biobank and Utah prostate cancer case data.
• 3D protein structure prediction to analyze pathogenicity of identified variants.

Main Results:

• Nearly 4000 rare variants (<0.005 frequency) were identified as shared among affected cousins.
• A rare variant in the LRBA gene demonstrated significant association with prostate cancer risk (p = 3.2 × 10^-5; OR = 2.09) and segregated in five pedigrees.
• 3D protein structure analysis indicated a loss of helical structure near the mutation site in LRBA, suggesting a potential mechanism of pathogenicity.

Conclusions:

• This study identified a set of candidate predisposition variants for prostate cancer, with strong evidence supporting a rare variant in the LRBA gene.
• The findings highlight the importance of analyzing closely related individuals in high-risk pedigrees for novel genetic discoveries.
• Further independent studies are warranted to validate these findings and explore the role of LRBA in prostate cancer pathogenesis.